Magusan, Sitti Alia G.
HRN: 24-36-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2025
CEFUROXIME 750MG (VIAL)
03/28/2025
04/03/2025
IV
300 Mg
Q8H
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes